3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Prostatic Neoplasms
8
Colonic Neoplasms
7
Neoplasms
5
Colorectal Neoplasms
5
Multiple Myeloma
4
Smoldering Multiple Myeloma
3
Monoclonal Gammopathy of Undetermined Significance
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Radiodermatitis
2
Pancreatic Neoplasms
2
Pain
2
Esophageal Neoplasms
2
Breast Carcinoma In Situ
2
Adenomatous Polyposis Coli
2
cyclopia sequence
1
Uterine Neoplasms
1
Tuberous Sclerosis
1
Thrombocythemia, Essential
1
Stomatitis
1
Sezary Syndrome
1
Seizures
1
Psychological Well-Being
1
Prostate Cancer Metastatic Castration Resistant
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Sirolimus
13
Everolimus
12
Vigabatrin
3
Activator Appliances
3
carbon-11 acetate
1
Urination
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Simvastatin
1
Sertraline
1
Selective Serotonin Reuptake Inhibitors
1
Propranolol
1
Phlebotomy
1
Genetic Testing
1
Fluid Therapy
1
Doxycycline
1
Curcumin
1
Calcitriol
1
Aspirin
1
Anticonvulsants
1
Actigraphy
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Tuberous Sclerosis
×
Curcumin
×
Clear all
NCT03254680
2018-04-30
Turmeric as Treatment in Epilepsy
NYU Langone Health
Phase NA
Withdrawn